Connection

Ryan Tedford to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Ryan Tedford has written about Treatment Outcome.
Ryan Tedford
Connection Strength
0.765
Treatment Outcome
  1. Outcomes in Patients With LVADs Undergoing Simultaneous Heart-Kidney Transplantation. J Card Fail. 2022 11; 28(11):1584-1592.
    View in: PubMed
    Score: 0.088
  2. Less invasive surgical implant strategy and right heart failure after LVAD implantation. J Heart Lung Transplant. 2021 04; 40(4):289-297.
    View in: PubMed
    Score: 0.080
  3. Recurrent but Preventable Pulseless Electrical Activity Arrest: Follow the Guidelines! Circ Heart Fail. 2020 03; 13(3):e006781.
    View in: PubMed
    Score: 0.076
  4. Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University. JAMA Cardiol. 2017 10 01; 2(10):1090-1099.
    View in: PubMed
    Score: 0.064
  5. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension. J Heart Lung Transplant. 2014 Mar; 33(3):289-97.
    View in: PubMed
    Score: 0.049
  6. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail. 2008 Nov; 1(4):213-9.
    View in: PubMed
    Score: 0.034
  7. Characteristics and Predictors of Late Right Heart Failure After Left Ventricular Assist Device Implantation. ASAIO J. 2023 03 01; 69(3):315-323.
    View in: PubMed
    Score: 0.023
  8. Effects of Body Mass Index on Presentation and Outcomes of COVID-19 among Heart Transplant and Left Ventricular Assist Device Patients: A Multi-Institutional Study. ASAIO J. 2023 01 01; 69(1):43-49.
    View in: PubMed
    Score: 0.022
  9. Outcomes in Patients With Chronic Kidney Disease and End-stage Renal Disease and Durable Left Ventricular Assist Device: Insights From the United States Renal Data System Database. J Card Fail. 2022 11; 28(11):1604-1614.
    View in: PubMed
    Score: 0.022
  10. Rate of thromboembolic and bleeding events in patients undergoing concomitant aortic valve surgery with left ventricular assist device implantation. Int J Cardiol. 2022 07 15; 359:39-45.
    View in: PubMed
    Score: 0.022
  11. HVAD versus heartmate III bridge to heart transplantation: Waitlist and posttransplant outcomes. Clin Transplant. 2022 03; 36(3):e14546.
    View in: PubMed
    Score: 0.021
  12. Impact of the 2018 change in US allocation policy on adults with congenital heart disease. J Heart Lung Transplant. 2022 03; 41(3):373-381.
    View in: PubMed
    Score: 0.021
  13. Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes. J Heart Lung Transplant. 2021 09; 40(9):926-935.
    View in: PubMed
    Score: 0.021
  14. Acute Hemodynamic Effects of Cardiac Resynchronization Therapy Versus Alternative Pacing Strategies in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2021 03 16; 10(6):e018127.
    View in: PubMed
    Score: 0.020
  15. Impact of preoperative liver dysfunction on outcomes in patients with left ventricular assist devices. Eur J Cardiothorac Surg. 2020 05 01; 57(5):920-928.
    View in: PubMed
    Score: 0.019
  16. Impact of Continuous Flow Left Ventricular Assist Device Therapy on Chronic Kidney Disease: A Longitudinal Multicenter Study. J Card Fail. 2020 Apr; 26(4):333-341.
    View in: PubMed
    Score: 0.019
  17. Reply: Can treprostinil-induced early gastrointestinal side effects serve as predictors of pulmonary arterial hypertension prognosis? Int J Cardiol. 2018 08 01; 264:188.
    View in: PubMed
    Score: 0.017
  18. Effects of Percutaneous LVAD Support on Right Ventricular Load and Adaptation. J Cardiovasc Transl Res. 2019 04; 12(2):142-149.
    View in: PubMed
    Score: 0.017
  19. A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis. J Card Fail. 2018 Jun; 24(6):384-391.
    View in: PubMed
    Score: 0.016
  20. Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2018 02 01; 197(3):388-391.
    View in: PubMed
    Score: 0.016
  21. Long-term follow-up of continuous flow left ventricular assist devices: complications and predisposing risk factors. Int J Artif Organs. 2017 Oct 27; 40(11):622-628.
    View in: PubMed
    Score: 0.016
  22. Pre-operative proteinuria in left ventricular assist devices and clinical outcome. J Heart Lung Transplant. 2018 01; 37(1):124-130.
    View in: PubMed
    Score: 0.016
  23. What's in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension. Int J Cardiol. 2017 Aug 01; 240:386-391.
    View in: PubMed
    Score: 0.015
  24. Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation. Ann Thorac Surg. 2016 Jul; 102(1):102-8.
    View in: PubMed
    Score: 0.014
  25. Comparative Efficacy of Cardiac Resynchronization Therapy in Africans Americans Compared With European Americans. Am J Cardiol. 2015 Oct 01; 116(7):1101-5.
    View in: PubMed
    Score: 0.014
  26. Long-term outcomes in patients with ambulatory new york heart association class III and IV heart failure undergoing cardiac resynchronization therapy. Am J Cardiol. 2015 Jan 01; 115(1):82-5.
    View in: PubMed
    Score: 0.013
  27. Electrocardiographic findings after acute, isolated, posterior myocardial infarction in a patient with pulmonary disease. Tex Heart Inst J. 2012; 39(2):292-3.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.